Plans for vaccine passes provoke protests in France, Switzerland and Italy
Video Credit: Euronews English - Duration: 01:20s - Published
Plans for vaccine passes provoke protests in France, Switzerland and Italy
Government plans to make access to public spaces conditional on health checks have provoked more protest demonstrations in France, Switzerland and Italy.
Every year dozens of British people travel to clinics there to end their lives, in a way they see fit. But now ITV News has seen evidence which appears to show one such clinic flouting Swiss guidelines - and the devastating consequences that can have. Alastair Hamilton was just 47 when he told his family he was going to Paris on holiday. He was actually flying to Switzerland. ITV News helped Alastair's mother and brother retrace his final days... and they wanted to share their devastation. Report by Covellm. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Nemo, this year's Eurovision winner, has stressed the importance of creating environments that promote love and unity and urged the contest's organisers to reflect on what Eurovision should stand for.
Credit: euronews (in English) Duration: 02:19Published
The White House said it was "deeply troubled" that parliament had passed the bill. The UK, Germany, Italy and France have also all urged Georgia to withdraw it.
Credit: euronews (in English) Duration: 02:25Published
PM Narendra Modi confident of overwhelming BJP victory in Lok Sabha elections, plans to attend G7 summit in Italy after taking oath as PM, as announced on Aaj.. IndiaTimes
New Analysis Suggests , Long-Term Effectiveness , for Wegovy Users .
NBC reports that patients taking
Novo Nordisk's obesity treatment maintain
an average of 10% weight loss over four years.
The news potentially boosts the
drugmaker's push for Wegovy to be
covered by insurers and governments. .
The company submitted long-term
findings at the European Congress
on Obesity in Venice, Italy. .
This is the longest study
we’ve conducted so far of
semaglutide for weight loss, Martin Holst Lange, Novo’s head of development, via NBC.
We see that once the majority
of the weight loss is accrued,
you don’t go back and start
to increase in weight
if you stay on the drug, Martin Holst Lange, Novo’s head of development, via NBC.
According to another analysis published by
the drugmaker, approximately 17% of trial participants stopped using the treatment
due to side effects like nausea. .
The costly treatment ranges from $200
to nearly $2,000 per month in the ten
countries where the drug is available.
NBC reports that Novo Nordisk was the
first drugmaker to market GLP-1 agonists,
originally developed as a diabetes treatment,
to address record high obesity rates.
NBC reports that Novo Nordisk was the
first drugmaker to market GLP-1 agonists,
originally developed as a diabetes treatment,
to address record high obesity rates.
Rival Eli Lilly launched its drug
Zepbound in the United States
in December of 2023. .
Neither drugmaker has managed
to produce enough of the
treatment to meet surging demand
Credit: Wibbitz Top Stories Duration: 01:31Published
Prior to her Monday meetings with Italian political leaders, von der Leyen was a guest on national TV, where she spoke about the need to defend Ukraine against Russia's aggression to preserve peace in Europe.
Credit: euronews (in English) Duration: 02:00Published
Large protests are underway in Paris and many other cities on Saturday Aug 7, 2021 for the fourth weekend straight in France against vaccine passports Pass Sanitaire and mandatory vaccinations. The new..
NYC Will Require Proof of Vaccine, , for Indoor Dining,
Performances and Gyms.
The new policy was announced by
NYC Mayor Bill de Blasio on Aug. 3.
The policy mirrors those
that have been..
Credit: Wibbitz Top Stories Duration: 01:31Published